1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 35165101 | Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial. | 2022 May 13 | 1 |